{"id":"https://openalex.org/W4416628955","doi":"https://doi.org/10.1158/1078-0432.30707840","title":"Supplementary table 4 from Targeting MDSC Differentiation Using ATRA: A Phase I/II Clinical Trial Combining Pembrolizumab and All-Trans Retinoic Acid for Metastatic Melanoma","display_name":"Supplementary table 4 from Targeting MDSC Differentiation Using ATRA: A Phase I/II Clinical Trial Combining Pembrolizumab and All-Trans Retinoic Acid for Metastatic Melanoma","publication_year":2025,"publication_date":"2025-11-25","ids":{"openalex":"https://openalex.org/W4416628955","doi":"https://doi.org/10.1158/1078-0432.30707840"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.30707840","doi":"https://doi.org/10.1158/1078-0432.30707840","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.30707840","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.30707840","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036757902","display_name":"Richard P. Tobin","orcid":"https://orcid.org/0000-0003-3890-4534","observed_orcids":["https://orcid.org/0000-0003-3890-4534"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard P. Tobin","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3890-4534","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003236308","display_name":"Dasha T. Cogswell","orcid":"https://orcid.org/0000-0002-8518-5918","observed_orcids":["https://orcid.org/0000-0002-8518-5918"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dasha T. Cogswell","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8518-5918","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040257951","display_name":"Victoria M. Cates","orcid":"https://orcid.org/0000-0001-7803-7792","observed_orcids":["https://orcid.org/0000-0001-7803-7792"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Victoria M. Cates","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7803-7792","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075734879","display_name":"Dana M. Davis","orcid":"https://orcid.org/0000-0003-1775-1057","observed_orcids":["https://orcid.org/0000-0003-1775-1057"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dana M. Davis","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1775-1057","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022157436","display_name":"Jessica S.W. Borgers","orcid":"https://orcid.org/0000-0002-6478-7821","observed_orcids":["https://orcid.org/0000-0002-6478-7821"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jessica S.W. Borgers","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6478-7821","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062356933","display_name":"Robert J. Van Gulick","orcid":"https://orcid.org/0000-0002-6300-9569","observed_orcids":["https://orcid.org/0000-0002-6300-9569"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert J. Van Gulick","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6300-9569","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030901321","display_name":"Elizabeth N. Katsnelson","orcid":"https://orcid.org/0000-0001-7987-3768","observed_orcids":["https://orcid.org/0000-0001-7987-3768"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elizabeth Katsnelson","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7987-3768","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034522474","display_name":"Kasey L. Couts","orcid":"https://orcid.org/0000-0002-2088-2229","observed_orcids":["https://orcid.org/0000-0002-2088-2229"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kasey L. Couts","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2088-2229","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028795439","display_name":"Kimberly Rae Jordan","orcid":"https://orcid.org/0000-0001-8380-7157","observed_orcids":["https://orcid.org/0000-0001-8380-7157","https://orcid.org/0000-0001-5290-1677"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kimberly R. Jordan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8380-7157","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042355911","display_name":"Dexiang Gao","orcid":"https://orcid.org/0000-0003-3920-7060","observed_orcids":["https://orcid.org/0000-0003-3920-7060"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dexiang Gao","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3920-7060","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059109064","display_name":"Eduardo Davila","orcid":"https://orcid.org/0000-0003-3943-7974","observed_orcids":["https://orcid.org/0000-0003-3943-7974","https://orcid.org/0000-0001-9738-4167"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eduardo Davila","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3943-7974","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029723783","display_name":"Theresa Michelle Medina","orcid":"https://orcid.org/0000-0003-0579-4121","observed_orcids":["https://orcid.org/0000-0003-0579-4121"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Theresa M. Medina","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0579-4121","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010628808","display_name":"Karl D. Lewis","orcid":"https://orcid.org/0000-0001-9893-0537","observed_orcids":["https://orcid.org/0000-0001-9893-0537"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Karl D. Lewis","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9893-0537","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002655892","display_name":"Rene C. Gonzalez","orcid":"https://orcid.org/0000-0002-7435-6208","observed_orcids":["https://orcid.org/0000-0002-7435-6208"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rene Gonzalez","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7435-6208","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087182865","display_name":"Ross W. McFarland","orcid":"https://orcid.org/0000-0002-9577-0176","observed_orcids":["https://orcid.org/0000-0002-9577-0176"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ross W. McFarland","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9577-0176","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034106929","display_name":"William Allen Robinson","orcid":"https://orcid.org/0000-0003-1875-9691","observed_orcids":["https://orcid.org/0000-0003-1875-9691"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William A. Robinson","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1875-9691","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5036784999","display_name":"Martin D. McCarter","orcid":"https://orcid.org/0000-0001-8174-1713","observed_orcids":["https://orcid.org/0000-0001-8174-1713"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Martin D. McCarter","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8174-1713","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.7943999767303467,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.7943999767303467,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.11829999834299088,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.0544000007212162,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.8759999871253967},{"id":"https://openalex.org/keywords/all-trans-retinoic-acid","display_name":"all-trans retinoic acid","score":0.8849999904632568},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9760000109672546},{"id":"https://openalex.org/keywords/myeloid-derived-suppressor-cells","display_name":"myeloid-derived suppressor cells","score":0.8740000128746033},{"id":"https://openalex.org/keywords/mdsc-differentiation","display_name":"MDSC differentiation","score":0.7110000252723694},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.6570000052452087},{"id":"https://openalex.org/keywords/clinical-benefit","display_name":"clinical benefit","score":0.6539999842643738},{"id":"https://openalex.org/keywords/patient-characteristics","display_name":"patient characteristics","score":0.8769999742507935}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.777400016784668},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.7717999815940857},{"id":"https://openalex.org/C2994587330","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Metastatic melanoma","level":3,"score":0.7631000280380249},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.6711000204086304},{"id":"https://openalex.org/C2781121885","wikidata":"https://www.wikidata.org/wiki/Q425517","display_name":"Retinoic acid","level":3,"score":0.6513000130653381},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.507099986076355},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4900999963283539},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4611999988555908},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.45820000767707825},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.40880000591278076},{"id":"https://openalex.org/C2779963572","wikidata":"https://www.wikidata.org/wiki/Q29417","display_name":"Tretinoin","level":4,"score":0.39989998936653137},{"id":"https://openalex.org/C45235069","wikidata":"https://www.wikidata.org/wiki/Q278425","display_name":"Table (database)","level":2,"score":0.3849000036716461},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.29589998722076416},{"id":"https://openalex.org/C44280652","wikidata":"https://www.wikidata.org/wiki/Q104837","display_name":"Phase (matter)","level":2,"score":0.290800005197525},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.26030001044273376}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.30707840","doi":"https://doi.org/10.1158/1078-0432.30707840","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.30707840","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/30707840","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_table_4_from_Targeting_MDSC_Differentiation_Using_ATRA_A_Phase_I_II_Clinical_Trial_Combining_Pembrolizumab_and_All-Trans_Retinoic_Acid_for_Metastatic_Melanoma/30707840","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.30707840","doi":"https://doi.org/10.1158/1078-0432.30707840","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.30707840","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4362479602","https://openalex.org/W4309223784","https://openalex.org/W3216156929","https://openalex.org/W3170788948","https://openalex.org/W2886331090","https://openalex.org/W4317433660","https://openalex.org/W2798251250","https://openalex.org/W4404064792","https://openalex.org/W4402561060","https://openalex.org/W4379283232"],"abstract_inverted_index":{"Characteristics":[0],"of":[1],"patients":[2],"experiencing":[3],"clinical":[4],"benefit":[5]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2025-11-25T00:00:00"}